Global DNA Polymerase Market: Overview
DNA polymerase is an enzyme which is necessary for assembling the nucleotides together on the DNA strand. DNA polymerase was discovered by Dr. Arthur Kornberg in 1955 in an E.coli cell. He had first discovered the DNA polymerase I. DNA polymerase is also an essential enzyme for DNA replication. With each cell division, DNA polymerase is required for the duplication of the cell’s DNA. It is through this that the genetic information is passed from one generation to the other. DNA polymerase functions by adding new nucleotide at the 3’ end of the new DNA strand. DNA polymerase also helps in correcting the mistakes in the new synthesized strand by the process known as ‘proofreading.’ In this process, incorrect coupling is recognized by DNA polymerase which then reverses its direction by one base pair. The incorrect part is further removed by the process called as excision. DNA polymerase is essential for the process of transcription and translation which results in protein synthesis.
Global DNA Polymerase Market: Drivers and Restraints
There is a huge potential for the growth of the DNA polymerase market with the increasing incidence of cancer, neurological disorders, genetic mutation, and due to the increasing number of chronic diseases. According to WHO, the number of deaths due to cancer is expected to increase more than 70% over a decade. Also, increasing number of recombinant medicines for treating chronic diseases will drive the growth of the DNA polymerase market. Increasing crime across globe will boost the use of DNA polymerase in forensic testing such as DNA fingerprinting, which will drive the growth of the market. However, few restraining factors such as high cost, ethical issues, and stringent regulatory approval are likely to slow the growth of the DNA polymerase market.
Global DNA Polymerase Market: Key Segments
The DNA polymerase market is segmented in terms of cell type, therapeutic application, according to the reagents used, end users, and geography. According to cell type, the DNA polymerase market is segmented into prokaryotes and eukaryotes. Prokaryotes are further segmented into DNA polymerase I, DNA polymerase II, DNA polymerase III, DNA polymerase IV, and DNA polymerase V. Based on Eukaryotes, the DNA polymerase market is further segmented into DNA polymerase α, δ and € and DNA polymerase γ. In terms of therapeutic application, DNA polymerase is used in treating cancer, neuro-generative diseases, genetic disorders, and also in forensic labs. Based on reagents used, the DNA polymerase market is segmented into antibodies, primers, buffers, and other reagents used. In terms of end users, the market is segmented into biotechnology companies, diagnostic centers, research institutes, and forensic laboratories.
According to geography, the DNA polymerase market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominates the DNA polymerase market in terms of geography due to extensive research carried out in this region and also due to well-structured healthcare facilities with advanced treatments. Europe is the second largest market for DNA polymerase due to wide-ranging research activities carried out in this region with all major companies owning high stakes in the region. Increasing mergers and acquisitions with medical technology being widely used has facilitated the growth of the DNA polymerase market. Asia Pacific is a lucrative market backed by countries such as India, China, and Japan. Increasing interest of top players in this region due to improving economic conditions and developing healthcare infrastructure are the major drivers of the DNA polymerase market. Also, extensive research carried out in this region and growing awareness regarding genetic testing is an important factor for the growth of the market. Latin America, and Middle East & Africa are emerging markets and are expected to expand at a significant growth rate.
Global DNA Polymerase Market: Key Players
The top players in the DNA polymerase market are Novus, Excell Bio, Biomiga, Stratagene, SYGNIS, F. Hoffmann-La Roche Ltd, Finnzymes, Cyagen, Tiangen, Genetimes and others.
This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.
Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:
- Customer Experience Maps
- Insights and Tools based on data-driven research
- Actionable Results to meet all the business priorities
- Strategic Frameworks to boost the growth journey
The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.
The following regional segments are covered comprehensively:
- North America
- Asia Pacific
- Latin America
- The Middle East and Africa
The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.
Below is a snapshot of these quadrants.
1. Customer Experience Map
The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.
2. Insights and Tools
The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.
3. Actionable Results
The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.
4. Strategic Frameworks
The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
1. What can be the best investment choices for venturing into new product and service lines?
2. What value propositions should businesses aim at while making new research and development funding?
3. Which regulations will be most helpful for stakeholders to boost their supply chain network?
4. Which regions might see the demand maturing in certain segments in near future?
5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
7. Which government regulations might challenge the status of key regional markets?
8. How will the emerging political and economic scenario affect opportunities in key growth areas?
9. What are some of the value-grab opportunities in various segments?
10. What will be the barrier to entry for new players in the market?
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.